GenoMed is a medical genomics company that's pioneering preventive molecular medicine. We find disease-causing genes, then work out "recipes," using existing medications whenever possible, to significantly delay or even reverse the disease. We patent our methods, and charge patients a license fee to use them.
Unfortunately, we've had to invent this unusual business model because health plans don't pay a dime for prevention. All their revenues come from the hospital.
So far, we've published superior patient outcomes for diabetes, hypertension, chronic renal failure, and COPD.
Diseases in phase IV trials include all cancers, autoimmune diseases, and viral diseases. Trials are free to the patient.
Primary care providers and their patients are encouraged to contact us for the latest info.